BRITISH COLUMBIA INVESTMENT MANAGEMENT CORP – Vertex Pharmaceuticals Incorporated Transaction History
BRITISH COLUMBIA INVESTMENT MANAGEMENT CORP portfolio value:
$7.32M
portfolio value
BRITISH COLUMBIA INVESTMENT MANAGEMENT CORP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -14.46% | -4.27K shares | -1.00M | $289.54 | 25.30K |
| Q2 2022 | share | Decrease | -24.64% | -9.67K shares | -1.90M | $281.79 | 29.57K |
| Q1 2022 | share | Decrease | -13.94% | -6.36K shares | 228K | $260.97 | 39.25K |
| Q4 2021 | share | Decrease | -4.87% | -2.33K shares | 1.31M | $222.45 | 45.61K |
| Q3 2021 | share | Decrease | -0.27% | -131 shares | -997K | $181.39 | 47.94K |
| Q2 2021 | share | Increase | +12.74% | 5.43K shares | 530K | $201.63 | 48.08K |
| Q1 2021 | share | Decrease | -3.26% | -1.43K shares | -1.25M | $214.89 | 42.64K |
| Q4 2020 | share | Decrease | -2.09% | -940 shares | -1.83M | $236.34 | 44.08K |
| Q3 2020 | share | Increase | +8.36% | 3.47K shares | 189K | $272.12 | 45.02K |
| Q2 2020 | share | Increase | +47.49% | 13.37K shares | 5.35M | $290.31 | 41.54K |
| Q1 2020 | share | Decrease | -53.56% | -32.48K shares | -6.57M | $237.95 | 28.17K |
| Q4 2019 | share | Decrease | -42.92% | -45.60K shares | -4.72M | $218.95 | 60.65K |
| Q3 2019 | share | Decrease | -10.55% | -12.52K shares | -3.78M | $169.42 | 106.25K |
| Q2 2019 | share | Increase | +5.03% | 5.69K shares | 980K | $183.38 | 118.78K |
| Q1 2019 | share | Increase | +3.27% | 3.58K shares | 2.65M | $183.95 | 113.09K |
| Q4 2018 | share | Increase | +30.26% | 25.44K shares | 1.94M | $165.71 | 109.51K |
| Q3 2018 | share | Decrease | -23.88% | -26.37K shares | -2.56M | $192.74 | 84.06K |
| Q2 2018 | share | Decrease | -18.62% | -25.27K shares | -3.34M | $169.96 | 110.44K |
| Q1 2018 | share | Decrease | -6.73% | -9.79K shares | 314K | $162.98 | 135.71K |
| Q4 2017 | share | Decrease | -28.10% | -56.86K shares | -8.96M | $149.86 | 145.50K |
| Q3 2017 | share | Decrease | -5.29% | -11.30K shares | 3.23M | $152.04 | 202.37K |
| Q2 2017 | share | Increase | +51.38% | 72.52K shares | 12.10M | $128.87 | 213.68K |
| Q1 2017 | share | Decrease | -4.62% | -6.84K shares | 4.53M | $109.35 | 141.15K |
| Q4 2016 | share | Decrease | -3.53% | -5.41K shares | -2.47M | $73.67 | 148K |
| Q3 2016 | share | Decrease | -11.16% | -19.26K shares | -1.47M | $87.21 | 153.41K |
| Q2 2016 | share | Decrease | -1.32% | -2.31K shares | 944K | $86.02 | 172.68K |
| Q1 2016 | share | Increase | +6.31% | 10.38K shares | -6.80M | $79.49 | 175.00K |